Compare ALGT & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALGT | VIR |
|---|---|---|
| Founded | 1997 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Air Freight/Delivery Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.5B |
| IPO Year | 2006 | 2019 |
| Metric | ALGT | VIR |
|---|---|---|
| Price | $82.49 | $9.04 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 10 | 8 |
| Target Price | ★ $97.30 | $19.63 |
| AVG Volume (30 Days) | 418.4K | ★ 2.2M |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 81.62 | 17.49 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,606,579,000.00 | $68,556,000.00 |
| Revenue This Year | $8.57 | N/A |
| Revenue Next Year | $6.86 | $1,049.62 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 3.74 | N/A |
| 52 Week Low | $39.82 | $4.16 |
| 52 Week High | $118.00 | $10.91 |
| Indicator | ALGT | VIR |
|---|---|---|
| Relative Strength Index (RSI) | 47.24 | 52.83 |
| Support Level | $58.66 | $8.67 |
| Resistance Level | $91.54 | $10.29 |
| Average True Range (ATR) | 4.38 | 0.46 |
| MACD | 0.90 | -0.09 |
| Stochastic Oscillator | 62.43 | 50.31 |
Allegiant Travel Co is a leisure travel company focused on providing travel and leisure services and products to residents of underserved cities in the United States. It operates a low-cost, low utilization passenger airline marketed to leisure travelers in underserved cities, allowing it to sell air transportation both on a stand-alone basis and bundled with the sale of air-related and third-party services and products. In addition, it provides air transportation under fixed-fee flight arrangements. In connection with its leisure travel focus, the company has opened Sunseeker Resort Charlotte Harbor, equipped with several guestrooms and food and beverage outlets. The company's operating segments are the Airline, which generates the maximum revenue, and Sunseeker Resort.
Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.